No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs573493798 |
chr8:10455854-10455855 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs564810894 |
chr8:10455862-10455863 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs116931496 |
chr8:10455910-10455911 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs112753321 |
chr8:10455915-10455916 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs75677449 |
chr8:10455917-10455918 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs577630525 |
chr8:10455937-10455938 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs535630006 |
chr8:10455956-10455957 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs185302057 |
chr8:10455973-10455974 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs572195713 |
chr8:10456006-10456007 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs541125778 |
chr8:10456011-10456012 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs558235206 |
chr8:10456018-10456019 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs115911502 |
chr8:10456064-10456065 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs568721333 |
chr8:10456071-10456072 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs189832873 |
chr8:10456079-10456080 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs563554607 |
chr8:10456106-10456107 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs529251726 |
chr8:10456107-10456108 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs9644729 |
chr8:10456111-10456112 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
18 |
rs559551892 |
chr8:10456121-10456122 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs528296080 |
chr8:10456128-10456129 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs149057617 |
chr8:10456129-10456130 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs143099405 |
chr8:10456138-10456139 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs530407434 |
chr8:10456171-10456172 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs181572995 |
chr8:10456172-10456173 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs540588217 |
chr8:10456174-10456175 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs529343422 |
chr8:10456257-10456258 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs535783122 |
chr8:10456302-10456303 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs138810639 |
chr8:10456325-10456326 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs79820479 |
chr8:10456364-10456365 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs535241686 |
chr8:10456398-10456399 |
Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs35088717 |
chr8:10456419-10456420 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs141360312 |
chr8:10456469-10456470 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs557935505 |
chr8:10456472-10456473 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs578070380 |
chr8:10456484-10456485 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs543451799 |
chr8:10456496-10456497 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs557432413 |
chr8:10456521-10456522 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs574093514 |
chr8:10456531-10456532 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs549591259 |
chr8:10456554-10456555 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs542898768 |
chr8:10456566-10456567 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs559708992 |
chr8:10456572-10456573 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs528241874 |
chr8:10456581-10456582 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs374201272 |
chr8:10456584-10456585 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs577792023 |
chr8:10456609-10456610 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs146988265 |
chr8:10456633-10456634 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs371246710 |
chr8:10456654-10456655 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs377498733 |
chr8:10456663-10456664 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs138171860 |
chr8:10456665-10456666 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs185883780 |
chr8:10456704-10456705 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs370595264 |
chr8:10456710-10456711 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs566879789 |
chr8:10456725-10456726 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs529644568 |
chr8:10456726-10456727 |
Enhancers Weak transcription Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|